X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: New Xcenda white paper looks at four strengths of Part B

By Nicole Longo  |    April 30, 2018
In case you missed it, a recent white paper from Xcenda took a deeper look at how Medicare Part B reimburses for physician-administered medicines and how the program has evolved over time. The...   Read More

Securely dispose of your unwanted medicines on National Take Back Day

By Caitlin Carroll  |    April 28, 2018
Today, the U.S. Drug Enforcement Administration hosts its annual National Prescription Drug Take Back Day. The awareness day helps educate people on the need to properly dispose of expired or...   Read More

Reality check: Value-based contracts are good for patients

By Michelle Drozd  |    April 25, 2018
Biopharmaceutical companies are joining stakeholders across the health care system to pursue flexible ways to pay for medicines that focus on results, lower out-of-pocket costs and enable patients...   Read More

Bringing innovation to clinical trial design

By Richard Moscicki, M.D.  |    April 23, 2018
Clinical trials are critical to the discovery and development of innovative medicines that enable patients to live longer, healthier lives. As the biopharmaceutical industry works to identify,...   Read More

Spending on medicines grew less than one percent in 2017

By Holly Campbell  |    April 19, 2018
Last year, a record number of new treatments and cures that are transforming care for patients fighting debilitating diseases like cancer, hepatitis C, high cholesterol and more were approved by...   Read More

A new era in Alzheimer’s innovation

By Andrew Powaleny  |    April 19, 2018
After heart disease and cancer, Alzheimer’s disease and dementia are the leading cause of death for seniors, responsible for one out of every three deaths. Today, the disease devastates the minds...   Read More

New report shows over 500 medicines in development for neurological disorders

By Andrew Powaleny  |    April 18, 2018
Neurological disorders, which include more than 1,000 conditions that disrupt the brain and nervous system, affect an estimated 100 million Americans, nearly one third of the U.S. population....   Read More

Video: Barriers to results-based contracts

By Katie Koziara  |    April 17, 2018
Research suggests results-based contracts (RBCs)—also known as value-based contracts—have the potential to lower costs for patients and the health system. According to a recent analysis, these...   Read More

Patients pay the price when hospitals mark up cancer medicines

By Joe Vandigo  |    April 5, 2018
Two studies released last month reveal how hospitals across the country mark up the price of medicines and deliver a growing share of provider-administered medicines, resulting in higher costs...   Read More

PPA celebrates 13 years of helping patients access their medicines

By Hannah Mooney  |    April 5, 2018
As of 2018, 13 is no longer an unlucky number, especially when it comes to health. This April, the Partnership for Prescription Assistance (PPA) is celebrating 13 years of connecting people who...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates